Stock data
| Market cap. | £345.8m |
| Last close | 769.50p |
| High / Low (52 weeks) | 795.0p / 665.5p |
| Stock market listing | LSE |
| Forecast net debt (m) | N/A |
| Forecast gearing ratio (%) | N/A |
| Team | Investment Companies & Trusts |
| Sector | Investment Trusts |
Price performance
| % | 1m | 3m | 12m |
|---|---|---|---|
| Actual | (1.16) | 0.13 | 3.15 |
| Relative * | 3.7 | 8.35 | 13.36 |
* % Relative to local index
Other companies covered in sector
Latest research
Healthcare valuations at historic lows
Review | Investment Trusts | 10/02/2012
Positive outlook for healthcare
Review | Investment Trusts | 24/06/2011
Strong performance with further growth potential
Review | Investment Trusts | 22/11/2010
Strong dividend growth with further growth potential
Review | Investment Trusts | 01/06/2010
Biotech and pharmaceuticals outlook remains positive
Update | Investment Trusts | 16/06/2009
The healing power of pharmaceuticals and biotech
Update | Investment Trusts | 12/02/2009
Investment summary
Worldwide Healthcare Trust PLC (WWH) is a UK-registered investment trust, offering diversified exposure to both the pharmaceutical and biotech sectors, and notable for its long track record. It has returned 13.0% in terms of both price and NAV total return during the past 12 months, slightly underperforming its benchmark, the MSCI World Healthcare Index (sterling adjusted), which returned 13.5%. Despite the uplift, valuations remain close to historical lows and, as such, significant upside potential remains. WWH has provided 76% year-on-year dividend growth for 2011 and its recent interims indicate that, at the halfway stage, it has sufficient revenue reserves to allow it to maintain the dividend at the increased level for 2012.
Last updated on 10/02/2012
Key management
| Martin Smith, Chairman |
| Samuel D Isaly, Fund manager |
Company address
| 25 Southampton Buildings London WC2A 1AL United Kingdom +44 (0) 203 0084910 View website |
